DK0947585T3 - Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter - Google Patents

Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter

Info

Publication number
DK0947585T3
DK0947585T3 DK98105043T DK98105043T DK0947585T3 DK 0947585 T3 DK0947585 T3 DK 0947585T3 DK 98105043 T DK98105043 T DK 98105043T DK 98105043 T DK98105043 T DK 98105043T DK 0947585 T3 DK0947585 T3 DK 0947585T3
Authority
DK
Denmark
Prior art keywords
coagulation
kits
reagents
conversion rate
screening
Prior art date
Application number
DK98105043T
Other languages
English (en)
Inventor
Bert Steffen Rosen
Christina Maria Yvonne Hall
Original Assignee
Instrumentation Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instrumentation Lab Spa filed Critical Instrumentation Lab Spa
Application granted granted Critical
Publication of DK0947585T3 publication Critical patent/DK0947585T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK98105043T 1998-03-19 1998-03-19 Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter DK0947585T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105043A EP0947585B1 (en) 1998-03-19 1998-03-19 Improved in vitro method, kits and reagents for screening for blood coagulation defects

Publications (1)

Publication Number Publication Date
DK0947585T3 true DK0947585T3 (da) 2001-10-01

Family

ID=8231624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98105043T DK0947585T3 (da) 1998-03-19 1998-03-19 Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter

Country Status (12)

Country Link
US (4) US6395501B1 (da)
EP (1) EP0947585B1 (da)
AT (1) ATE203567T1 (da)
AU (2) AU758831B2 (da)
CA (1) CA2334935C (da)
DE (1) DE69801210T2 (da)
DK (1) DK0947585T3 (da)
ES (1) ES2162361T3 (da)
GR (1) GR3036865T3 (da)
NZ (1) NZ506747A (da)
PT (1) PT947585E (da)
WO (1) WO1999047699A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
DE69801210T2 (de) * 1998-03-19 2002-05-02 Instrumentation Laboratory S.P.A., Mailand/Milano Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern
ES2231167T3 (es) 1999-02-04 2005-05-16 Biomerieux, Inc. Procedimiento y aparato para predecir la disfuncion hemostatica en una muestra de un paciente.
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
EP1260817A3 (en) 2001-05-08 2002-12-18 Warner-Lambert Company Method for direct measurement of coagulation factor VIIa activity in plasma
JP2004535461A (ja) * 2001-07-19 2004-11-25 ディーエムアイ バイオサイエンシズ インコーポレイテッド プロテインｃの不活性化を抑制するための銅キレート剤の使用
US6902904B2 (en) * 2001-08-27 2005-06-07 Pharmanetics Incorporated Coagulation assay reagents containing lanthanides
EP1367135A1 (en) * 2002-05-29 2003-12-03 Pentapharm AG Improved method for the assessment of thrombin formation in blood or plasma
US20040091952A1 (en) * 2002-07-25 2004-05-13 Sysmex Corporation Reagent kit for detecting lupus anticoagulant
WO2005031303A2 (en) * 2003-09-22 2005-04-07 University Of North Carolina At Chapel Hill Soluble phospholipids for use in clotting factor assays
DE602005006633D1 (de) * 2004-02-06 2008-06-26 Sysmex Corp Reagenziensatz zum Nachweis von Lupus-Antikoagulant.
ES2357112T3 (es) * 2005-01-07 2011-04-18 Stichting Katholieke Universiteit Ensayo de hemostasia.
JP4639904B2 (ja) * 2005-03-30 2011-02-23 チッソ株式会社 蛍光活性を有するルシフェラーゼの活性増強方法
JP4609177B2 (ja) * 2005-04-28 2011-01-12 チッソ株式会社 カルシウム結合型発光蛋白質溶液の発光時間延長方法
US7957521B2 (en) * 2005-11-30 2011-06-07 On-Q Telecom Systems Co., Inc. Method and system for user prioritization within telecommunication services and in particular within call completion services
FR2908892B1 (fr) * 2006-11-21 2009-02-20 Hyphen Biomed Soc Par Actions Procede pour le dosage chromogenique de l'activite du facteur viii:c et necessaire de dosage chromogenique de l'activite du facteur viii:c,dans les plasmas ou les fractions therapeutiques
FR2909180B1 (fr) * 2006-11-29 2009-02-20 Diagnostica Stago Soc Par Acti Methode de mesure fonctionnelle de l'activite de la thrombomoduline plasmatique.
WO2010016762A1 (en) * 2008-08-05 2010-02-11 Synapse B.V. A method and assembly for measuring thrombin generation in plasma
US9057574B2 (en) 2012-06-14 2015-06-16 Ra Brands, L.L.C. Thumb safety for model 1911 handgun
JP6595247B2 (ja) * 2015-07-30 2019-10-23 シスメックス株式会社 凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット
JP6577778B2 (ja) * 2015-07-30 2019-09-18 シスメックス株式会社 凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット
CN110568117B (zh) * 2019-09-19 2022-03-22 青岛海洋生物医药研究院股份有限公司 一种多靶点抗血栓活性物质的液相色谱-质谱筛选方法
CN111707837A (zh) * 2020-05-29 2020-09-25 上海太阳生物技术有限公司 狼疮抗凝物确认试剂盒（凝固法）

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE203509C (da) *
DE3607559A1 (de) * 1986-03-07 1987-09-10 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet
US5055412A (en) * 1989-03-21 1991-10-08 Proksch Gary J Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5308756A (en) * 1991-11-20 1994-05-03 Baxter Diagnostics Inc. Protein S chromogenic assay
US5637452A (en) * 1992-10-02 1997-06-10 Analytical Control Systems, Inc. Kit for an initial screen for abnormal platelet condition comprising propyl gallate or tannin and a metal ion
DE4402631A1 (de) * 1994-01-29 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Gerinnungsparametern
ATE200225T1 (de) * 1994-04-22 2001-04-15 Sanquin Bloedvoorziening Mittel für die behandlung von störungen des blutgerinnungsprozess
DE59812615D1 (de) * 1997-04-25 2005-04-07 Pentapharm Ag Basel Verfahren zum funktionellen nachweis von störungen im protein c-system
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
AUPP159698A0 (en) * 1998-02-02 1998-02-26 Life Therapeutics Limited Improved blood coagulation test
US6245573B1 (en) * 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
DE69801210T2 (de) 1998-03-19 2002-05-02 Instrumentation Laboratory S.P.A., Mailand/Milano Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
AU2002235073B2 (en) * 2001-03-02 2007-02-01 T.A.C. Thrombosis And Coagulation Ab Protein C variants
US6902904B2 (en) * 2001-08-27 2005-06-07 Pharmanetics Incorporated Coagulation assay reagents containing lanthanides

Also Published As

Publication number Publication date
AU2003212064A1 (en) 2003-08-14
US20040235078A1 (en) 2004-11-25
AU2003212064B9 (en) 2005-11-24
US20020115127A1 (en) 2002-08-22
AU3033999A (en) 1999-10-11
ES2162361T3 (es) 2001-12-16
US6395501B1 (en) 2002-05-28
AU758831B2 (en) 2003-04-03
US6800450B2 (en) 2004-10-05
CA2334935C (en) 2009-10-13
EP0947585A1 (en) 1999-10-06
WO1999047699A1 (en) 1999-09-23
US6730490B2 (en) 2004-05-04
AU2003212064B2 (en) 2005-10-20
EP0947585B1 (en) 2001-07-25
ATE203567T1 (de) 2001-08-15
DE69801210T2 (de) 2002-05-02
GR3036865T3 (en) 2002-01-31
DE69801210D1 (de) 2001-08-30
NZ506747A (en) 2003-03-28
CA2334935A1 (en) 1999-09-23
PT947585E (pt) 2001-11-30
US7118880B2 (en) 2006-10-10
US20030199014A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
DK0947585T3 (da) Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter
DK622688A (da) Analysemetode og testsystem til bestemmelse af en analyt i en blodproeve
HK1052218A1 (zh) 含有用於檢測被分析物的尿素衍生物的組分
DK0463524T3 (da) Sammensætning og fremgangsmåde til analysering for ketonstoffer
ES2061459T3 (es) Procedimiento de ensayo de substancias fisiologicamente activas.
EA199800493A1 (ru) Анализ крови на соотношение активности фактора v для оценки вероятности заболевания тромбоэмболией
DE69411898D1 (de) Neue antikoagulant-cofaktor aktivität
DK314987D0 (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
DK173090A (da) Forbedrede ekstraktionsmetoder til fremstilling af thromboplastinreagenser
ES2154703T3 (es) Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
DK484682A (da) Fremgangsmaade til kvantitativ bestemmelse af blodkoagulationsfaktor xii i humant plasma
DK0830608T3 (da) Thromboseriskotest
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
NO953770L (no) Analysemetode
SE9403833D0 (sv) Analysförfarande och kit
WO2002012892A3 (en) Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
De Nicola Analytical Review: Factor VII (SPCA): Its Physiopathologic Significance
EP0406971B1 (en) Method and kit for determining the functional activity of protein S in human plasma
DK0587090T3 (da) Fremgangsmåde til bestemmelse af thromboseforårsagende lupus-antikoagulat-antistoffer.
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
EP4682903A3 (en) Clinical decision support system
ATE200710T1 (de) Verfahren zur diagnose von blutgerinnungsstörungen
Hucker et al. Evaluation of enzymic assay for paracetamol: Clinical and forensic experiences
HUT60039A (en) Method for detecting allergy to food proteins and screening test set applicable for said method
Tripodi Activated protein C (APC) resistance